Patent Assignment
Reel/Frame 008167/0271
Security Agreement
Recorded: 1996-10-08
Pages: 36
Assignor
CV THERAPEUTICS, INC.
Executed: 1996-09-27
Assignee
HAMBRECHT & QUIST TRANSITION CAPITAL, LLC
ONE BUSH STREET, SAN FRANCISCO, CALIFORNIA, 94104
Covered Properties
(26)
Cardioselective Aryloxy- and Arylthio-Hydroxypropylene-Piperazinyl Acetanilides Which Affect Calcium Entry
Patent:
4,567,264 →
Application:
06/495,904 →
Use of Sulfated Polysaccharides to Inhibit Pancreatic Cholesterol Esterase
Patent:
5,017,565 →
Application:
07/340,868 →
Use of Sulfated Polysaccharides to Decrease Cholesterol and Fatty Acid Absorption
Patent:
5,063,210 →
Application:
07/429,398 →
Mammalian Pancreatic Cholesterol Esterase
Patent:
5,173,408 →
Application:
07/434,899 →
Method for Recovering Purified 52,000 Dalton Fraction of Human Pancrea Tic Cholesterol Esterase Using Deae-Cellulose, Hydroxyapatite and Hepa Rin-Sepharose
Patent:
5,352,601 →
Application:
07/936,103 →
Method for Measuring Human Cholesterol Absorption Using Metabolically Stable Isotopes
Patent:
5,432,058 →
Application:
07/954,864 →
Novel Methods of Treatment Using Ranolazine and Related Piperazine Derivatives
Patent:
5,506,229 →
Application:
07/955,397 →
Methods and Reagents for Rflp Analysis of the Human Pancreatic Cholesterol Esterase Gene
Application:
08/053,308 →
Novel A1 Adenosine Receptor Agonists and Antagonists as Diuretics
Patent:
5,446,046 →
Application:
08/144,459 →
Pancreatic Cholesterol Esterase Inhibitor
Patent:
5,484,777 →
Application:
08/167,725 →
High Dose Ranolazine Formulations
Patent:
5,472,707 →
Application:
08/239,621 →
Use of Non-Absorbable Synthetic Sulfated Polysaccharides to Decrease Cholesterol Absorbtion
Patent:
5,616,570 →
Application:
08/283,723 →
Method for Recovering Purified 100,000 Moleculat Weight Fraction of Hu Man Pancreatic Cholesterol Esterase Using Heparin Agarose
Patent:
5,429,937 →
Application:
08/311,862 →
Method of Manufacturing Non-Absorbable Synthetic Sulfated Polysaccharides
Patent:
5,521,303 →
Application:
08/322,782 →
Xanthine Epoxides as A1 Adenosine Receptor Agonists and Antagonists
Patent:
5,631,260 →
Application:
08/330,640 →
Method for Recovering Purified 100,000 Dalton Molecular Weight Fractio N of Human Pancreatic Cholesterol Esterase
Patent:
5,492,822 →
Application:
08/386,433 →
Method of Manufacturing Non-Absorbable Synthetic Sulfated Polysaccharides
Application:
08/451,563 →
Peptides from Mammalian Pancreatic Cholesterol Esterase
Patent:
5,792,832 →
Application:
08/461,881 →
Thermal Transfer Image-Receiving Sheet
Patent:
5,705,451 →
Application:
08/462,889 →
Kidney Na/PO4 Cotransporter Antisense Oligonucleotide
Patent:
5,840,875 →
Application:
08/467,007 →
Novel A1 Adenosine Receptor Agonists and Antagonists
Patent:
5,668,139 →
Application:
08/470,113 →
Macrophage Lipid Chemoattractant
Patent:
5,663,450 →
Application:
08/470,974 →
Method of Treating Ulcers with Sulfated Polysaccharides
Patent:
5,679,375 →
Application:
08/481,751 →
Novel Methods of Treatment Using Ranolazine and Related Piperazine Derivatives
Patent:
5,906,988 →
Application:
08/628,836 →
Purine Inhibitors of Cyclin Dependent Kinase 2
Patent:
5,866,702 →
Application:
08/692,012 →
N6 Momoheterocyclic Substituted Adenosine Derivatives
Patent:
5,789,416 →
Application:
08/702,234 →
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 30, 1996
From: MACKMAN, RICHARD; LUM, ROBERT T.; SCHOW, STEVEN R.; WICK, MICHAEL M.
To: CV THERAPEUTICS
Reel/Frame 008158/0910 →
Security Agreement
Oct 4, 1996
From: CV THERAPEUTICS, INC.
To: HAMBRECHT & QUIST GUARANTY FINANCE, LLC
Reel/Frame 008133/0190 →
Assignment of Assignor's Interest
Nov 4, 1996
From: SCHREINER, GEORGE F.; LANGE, LOUIS G., III
To: CV THERAPEUTICS
Reel/Frame 008207/0150 →
Assignment of Assignor's Interest
Nov 7, 1996
From: LUM, ROBERT T.; PFISTER, JURG R.; SCHOW, STEVEN R.; WICK, MICHAEL M
To: CV THERAPEUTICS
Reel/Frame 008214/0192 →
Termination of Security Agreement
Mar 24, 2005
From: HAMBRECHT & QUIST GUARANTY FINANCE, LLC
To: CV THERAPEUTICS, INC.
Reel/Frame 015953/0657 →
Termination of Security Agreement
Mar 24, 2005
From: HAMBRECHT & QUIST TRANSITION CAPITAL, LLC
To: CV THERAPEUTICS, INC.
Reel/Frame 015953/0634 →
Assignment of Assignor's Interest
Sep 11, 2012
From: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
To: UNIVERSITY OF SOUTH FLORIDA
Reel/Frame 028932/0853 →
Merger
Dec 31, 2013
From: APEX MERGER SUB, INC.; CV THERAPEUTICS, INC.
To: GILEAD PALO ALTO, INC.
Reel/Frame 031864/0556 →
Assignment of Assignor's Interest
Dec 31, 2013
From: GILEAD PALO ALTO, INC.
To: GILEAD SCIENCES, INC.
Reel/Frame 031864/0586 →